668 related articles for article (PubMed ID: 23796770)
1. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
[TBL] [Abstract][Full Text] [Related]
3. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
4. H
Wu J; Pan W; Wang C; Dong H; Xing L; Hou J; Fang S; Li H; Yang F; Yu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239370
[No Abstract] [Full Text] [Related]
5. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.
Zhuan B; Wang X; Wang MD; Li ZC; Yuan Q; Xie J; Yang Z
Aging (Albany NY); 2020 Nov; 12(23):23684-23697. PubMed ID: 33221740
[TBL] [Abstract][Full Text] [Related]
6. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
7. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
[TBL] [Abstract][Full Text] [Related]
9. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
10. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
11. [Effects of adrenomedullin regulating inducible nitric oxide synthase on proliferation and apoptosis in hypoxic pulmonary artery smooth muscle cells].
Li CG; Dai AG; Huang CP
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 May; 21(2):187-91. PubMed ID: 21171340
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
[TBL] [Abstract][Full Text] [Related]
13. [Changes of endoplasmic reticulum stress-induced apoptosis in pulmonary tissue of rats with hypoxic pulmonary hypertension].
Fan XF; Li WJ; Chen ZQ; Wang XR; Kong XX; Mao SZ; Hu LG; Gong YS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):270-4. PubMed ID: 22097712
[TBL] [Abstract][Full Text] [Related]
14. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
[TBL] [Abstract][Full Text] [Related]
15. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
Li YX; Run L; Shi T; Zhang YJ
Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
[TBL] [Abstract][Full Text] [Related]
16. Effect of intermedin/adrenomedullin
Telli G; Tel BC; Yersal N; Korkusuz P; Gumusel B
Life Sci; 2018 Jan; 192():62-67. PubMed ID: 29162436
[TBL] [Abstract][Full Text] [Related]
17. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
18. Reduction of endoplasmic reticulum stress by 4-phenylbutyric acid prevents the development of hypoxia-induced pulmonary arterial hypertension.
Koyama M; Furuhashi M; Ishimura S; Mita T; Fuseya T; Okazaki Y; Yoshida H; Tsuchihashi K; Miura T
Am J Physiol Heart Circ Physiol; 2014 May; 306(9):H1314-23. PubMed ID: 24610918
[TBL] [Abstract][Full Text] [Related]
19. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
20. Carvacrol induces the apoptosis of pulmonary artery smooth muscle cells under hypoxia.
Zhang Q; Fan K; Wang P; Yu J; Liu R; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2016 Jan; 770():134-46. PubMed ID: 26607464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]